EUVIMEDEUVIMED felfedezése
ÜbersichtsarbeitOpen access

Epigenetic regulation espeically histone modifications in breast cancer: A viable and emerging targeted therapeutic strategy

Yibing Zhou, Haotian Liu, Weimin Hong, Haotian Su, Yuxiao Mu, Yijie Cheng, Chaoshen Wu, Xuli Meng, Da Qian

Journal of Cancer · 2025-09-22 · 16 (13) · 4037-4046

DOI: 10.7150/jca.119306 ↗

At a glance

Übersichtsarbeit in Journal of Cancer, published on 2025-09-22. Written by Yibing Zhou and 8 co-authors. Institution: Central Laboratory, Department of Scientific Research, Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu,…. Cited 5 times so far (Crossref). The full text is freely available in PubMed Central.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Epigenetic regulation, encompassing DNA methylation, histone modifications, and non-coding RNA activities, is a crucial mechanism through which gene expression is modified without corresponding changes in genomic DNA sequences. Dysregulation of these mechanisms can lead to histone and DNA modifications that either suppress or enhance the expression of disease progression-related genes. Among these regulatory processes, histone modifications are particularly significant, as they contribute to genomic stability, DNA repair, and chromatin dynamics, all of which influence breast cancer initiation and progression. This review offers a detailed analysis of the current state of research centered on epigenetic regulatory factors, with a particular focus on the role that histone modifications play in the treatment of breast cancer. It also examines the interplay between epigenetic modifications and the effectiveness of radiotherapy and chemotherapy when treating breast cancer. Lastly, this article explores the potential of epigenetic regulatory factors as viable targets for the future design of new anticancer therapies.

Subjects

Author keywords

DNA methylation inhibitorsbreast cancerepigenetic regulationhistone modificationhistone target inhibitors

Authors and institutions

  • Central Laboratory, Department of Scientific Research, Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu, 215500, Jiangsu Province, China.
  • General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, 310014, Zhejiang Province, China.
  • Department of Pharmacy, The Third Affiliated Hospital (The Affiliated Luohu Hospital) of Shenzhen University, Shenzhen, 518001, China.
  • Department of Pharmacy, Changshu Hospital Affiliated to Soochow University, Changshu No. 1 People's Hospital, Changshu, 215500, Jiangsu Province, China.

Cite

APA

Zhou, Y., Liu, H., Hong, W., Su, H., Mu, Y., Cheng, Y., Wu, C., Meng, X., & Qian, D. (2025). Epigenetic regulation espeically histone modifications in breast cancer: A viable and emerging targeted therapeutic strategy. Journal of Cancer, 16(13), 4037-4046. https://doi.org/10.7150/jca.119306

Vancouver

Zhou Y, Liu H, Hong W, Su H, Mu Y, Cheng Y, et al. Epigenetic regulation espeically histone modifications in breast cancer: A viable and emerging targeted therapeutic strategy. Journal of Cancer. 2025;16(13):4037-4046. doi:10.7150/jca.119306

BibTeX
@article{Zhou2025,
  author = {Zhou, Yibing and Liu, Haotian and Hong, Weimin and Su, Haotian and Mu, Yuxiao and Cheng, Yijie and Wu, Chaoshen and Meng, Xuli and Qian, Da},
  title = {Epigenetic regulation espeically histone modifications in breast cancer: A viable and emerging targeted therapeutic strategy},
  journal = {Journal of Cancer},
  year = {2025},
  volume = {16},
  number = {13},
  pages = {4037--4046},
  doi = {10.7150/jca.119306}
}
Start for free →